Precision oncology with selective RET inhibitor selpercatinib in RET-rearranged cancers

Rearranged during transfection (RET) is a protooncogene that encodes for receptor tyrosine kinase with downstream effects on multiple cellular pathways. Activating RET alterations can occur and lead to uncontrolled cellular proliferation as a hallmark of cancer development. Oncogenic RET fusions are...

Descripción completa

Detalles Bibliográficos
Autores principales: Gouda, Mohamed A., Subbiah, Vivek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288430/
https://www.ncbi.nlm.nih.gov/pubmed/37360768
http://dx.doi.org/10.1177/17588359231177015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288430/
https://www.ncbi.nlm.nih.gov/pubmed/37360768
http://dx.doi.org/10.1177/17588359231177015

Ejemplares similares